Global Adeno-Associated Virus Vector Manufacturing Market to Reach USD 3.21 Billion by 2030, Driven by Advancements in Gene Therapy

Global Adeno Associated Virus Vector Manufacturing Market Size Expected to Reach USD 3.21 Billion by 2030, Growing at a CAGR of 12.8%

Global Adeno Associated Virus Vector Manufacturing Market to Witness Significant Growth, Projected to Reach USD 3.21 Billion by 2030

Summary: The Global Adeno Associated Virus (AAV) Vector Manufacturing Market is experiencing significant growth due to advancements in gene therapy research, the increasing demand for gene-based treatments, and the expanding applications of AAV vectors across industries. With an anticipated compound annual growth rate (CAGR) of approximately 12.8%, the market is expected to reach USD 3.21 billion by 2030. This growth is attributed to rising demand in gene therapy, cell therapy, and vaccine applications, with major players actively driving innovation in the sector.
read more..